Lipocine
LPCN
LPCN
33 hedge funds and large institutions have $5.42M invested in Lipocine in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
18% more funds holding
Funds holding: 28 → 33 (+5)
0.08% more ownership
Funds ownership: 0.45% → 0.53% (+0.08%)
Holders
33
Holding in Top 10
–
Calls
$172K
Puts
$13K
Top Buyers
| 1 | +$252K | |
| 2 | +$191K | |
| 3 | +$122K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$76K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$70K |
Top Sellers
| 1 | -$104K | |
| 2 | -$25K | |
| 3 | -$6K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.27K |